Tennessee HB2246 regulates stem cell therapies, requiring physicians to follow specific practices and obtain patient consent.
Tennessee HB2246 amends state law to regulate stem cell therapies. It mandates that physicians follow current good manufacturing practices and obtain signed consent forms from patients before performing stem cell therapies. The consent form must detail the treatment's nature, its unapproved status by the FDA, anticipated results, and potential risks. Stem cell therapies must be performed using cells from FDA-registered facilities or those accredited by specified organizations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.